Literature DB >> 15541478

Normal neutrophil maturation is associated with selective loss of MAP kinase activation by G-CSF.

Michael Baumann1, Tricia Frye, Tahir Naqvi, Julian Gomez-Cambronero.   

Abstract

Although both GM-CSF and G-CSF activate p42/44 MAPK in neutrophil progenitors, the ability of G-CSF to cause MAPK activation is lost in mature neutrophils, while GM-CSF exposure still causes activation. The mechanism of this differential effect related to maturation status has not been explored. We verified that G-CSF and GM-CSF receptors remain functional on purified mature neutrophils by demonstrating that both cytokines caused phosphorylation of STAT3. However, only GM-CSF was capable of activating MAPK as assessed by gel shift and in vitro kinase assay. Both G-CSF and GM-CSF caused activation of p21 ras in neutrophils, demonstrating that early events in the ras-MAPK pathway remain functional after stimulation by either cytokine. Inhibition of tyrosine phosphatase activity by pervanadate restored the ability of G-CSF to activate MAPK in mature neutrophils. Specific inhibition of the SHP-1 phosphatase, known to be activated by G-CSF but not GM-CSF also restored the ability of G-CSF to activate MAPK in neutrophils. These studies suggest that G-CSF activation of SHP-1 may be an important regulatory step for permitting optimal terminal differentiation during neutrophil production and add to our knowledge of the instructional role of G-CSF and GM-CSF for balancing proliferation and differentiation of neutrophil progenitor cells. This information may prove useful for the understanding of conditions in which neutrophil proliferative/differentiative balancing is dysregulated, such as myeloid leukemia and myelodysplastic disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15541478      PMCID: PMC3093195          DOI: 10.1016/j.leukres.2004.05.009

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  13 in total

1.  The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.

Authors:  S M Pettiford; R Herbst
Journal:  Oncogene       Date:  2000-02-17       Impact factor: 9.867

Review 2.  Molecular analysis of the granulocyte colony-stimulating factor receptor.

Authors:  B R Avalos
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

3.  Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice.

Authors:  P Tapley; N K Shevde; P A Schweitzer; M Gallina; S W Christianson; I L Lin; R B Stein; L D Shultz; J Rosen; P Lamb
Journal:  Exp Hematol       Date:  1997-02       Impact factor: 3.084

4.  Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival.

Authors:  J F Seymour; G J Lieschke; D Grail; C Quilici; G Hodgson; A R Dunn
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

5.  Modulation of MEK activity during G-CSF signaling alters proliferative versus differentiative balancing.

Authors:  M A Baumann; C C Paul; S Lemley-Gillespie; M Oyster; J Gomez-Cambronero
Journal:  Am J Hematol       Date:  2001-10       Impact factor: 10.047

6.  Human cell line that differentiates to all myeloid lineages and expresses neutrophil secondary granule genes.

Authors:  C C Paul; E Aly; J A Lehman; S M Page; J Gomez-Cambronero; S J Ackerman; M A Baumann
Journal:  Exp Hematol       Date:  2000-12       Impact factor: 3.084

7.  Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.

Authors:  M K Pathak; T Yi
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

8.  The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.

Authors:  A C Ward; S P Oomen; L Smith; J Gits; D van Leeuwen; A A Soede-Bobok; C A Erpelinck-Verschueren; T Yi; I P Touw
Journal:  Leukemia       Date:  2000-07       Impact factor: 11.528

9.  S6 kinase p90rsk in granulocyte-macrophage colony-stimulating factor-stimulated proliferative and mature hematopoietic cells.

Authors:  D E Joseph; C C Paul; M A Baumann; J Gomez-Cambronero
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

10.  Proliferative but not nonproliferative responses to granulocyte colony-stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway.

Authors:  A Bashey; L Healy; C J Marshall
Journal:  Blood       Date:  1994-02-15       Impact factor: 22.113

View more
  3 in total

1.  Orientation-specific signalling by thrombopoietin receptor dimers.

Authors:  Judith Staerk; Jean-Philippe Defour; Christian Pecquet; Emilie Leroy; Hélène Antoine-Poirel; Ian Brett; Miki Itaya; Steven O Smith; William Vainchenker; Stefan N Constantinescu
Journal:  EMBO J       Date:  2011-09-02       Impact factor: 11.598

Review 2.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

3.  SIRT1-SIRT7 Expression in Patients with Lymphoproliferative Disorders Undergoing Hematopoietic Stem Cell Mobilization.

Authors:  Mateusz Nowicki; Agnieszka Wierzbowska; Emilia Stec-Martyna; Dominika Kulczycka-Wojdala; Grzegorz Nowicki; Anna Szmigielska-Kapłon
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.